Targeting the IL34-CSF1R axis improves metastatic renal cell carcinoma therapy outcome via immune-vascular crosstalk regulation
Author:
Andrea Emanuelli,Wilfried Souleyreau,Tiffanie Chouleur,Bram Boeckx,Yasmine Pobiedonoscew,Lindsay Cooley,Marie-Alix Derieppe,Julie Martineau,Damien Ambrosetti,Jean-Christophe Bernhard,Catherine M. Sawai,Diether Lambrechts,Thomas Mathivet et al.
© 2025 The Author(s). Published by Elsevier Inc.